StockData
Pro Dex Inc logo

Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3012% below fair value
$61.93−2.55 (-3.95%)

Close on Nov 17, 2026Market cap $198.18MP/E 17.1Yield –

Pro Dex operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Pro Dex's operating cash flow for the twelve months ending Sep 30, 2026 was $11.42M. For fiscal 2026 it was $7.24M. Over ten years it grew 31.6% a year on average. The highest annual figure on record is $7.24M in fiscal 2026.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$7.24M–
FY2025Jun 30, 2025-$1.68M-127.0%
FY2024Jun 30, 2024$6.22M+14.0%
FY2023Jun 30, 2023$5.46M–
FY2022Jun 30, 2022-$847.00K–
FY2021Jun 30, 2021-$2.08M-142.0%
FY2020Jun 30, 2020$4.95M+48.7%
FY2019Jun 30, 2019$3.33M+7.4%
FY2018Jun 30, 2018$3.10M-4.3%
FY2017Jun 30, 2017$3.24M+594.2%
FY2016Jun 30, 2016$466.00K–
FY2015Jun 30, 2015-$775.00K–
FY2014Jun 30, 2014-$329.00K–
FY2013Jun 30, 2013-$1.27M-2924.4%
FY2012Jun 30, 2012$45.00K-98.4%
FY2011Jun 30, 2011$2.90M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$6.49M+181.0%
Q4 FY2026CQ2 2026Jun 30, 2026-$273.00K–
Q3 FY2026CQ1 2026Mar 31, 2026$1.63M+116.6%
Q2 FY2026CQ4 2025Dec 31, 2025$3.57M–
Q1 FY2026CQ3 2025Sep 30, 2025$2.31M+22.4%
Q4 FY2025CQ2 2025Jun 30, 2025-$173.00K-116.6%
Q3 FY2025CQ1 2025Mar 31, 2025$754.00K-81.5%
Q2 FY2025CQ4 2024Dec 31, 2024-$4.15M-684.5%
Q1 FY2025CQ3 2024Sep 30, 2024$1.89M+381.4%
Q4 FY2024CQ2 2024Jun 30, 2024$1.05M+66.7%
Q3 FY2024CQ1 2024Mar 31, 2024$4.08M+74.4%
Q2 FY2024CQ4 2023Dec 31, 2023$710.00K–
Q1 FY2024CQ3 2023Sep 30, 2023$392.00K-86.4%
Q4 FY2023CQ2 2023Jun 30, 2023$627.00K–
Q3 FY2023CQ1 2023Mar 31, 2023$2.34M+997.7%
Q2 FY2023CQ4 2022Dec 31, 2022-$395.00K-126.0%
Q1 FY2023CQ3 2022Sep 30, 2022$2.89M+7.1%
Q4 FY2022CQ2 2022Jun 30, 2022-$5.28M-828.1%
Q3 FY2022CQ1 2022Mar 31, 2022$213.00K–
Q2 FY2022CQ4 2021Dec 31, 2021$1.52M-23.1%
Q1 FY2022CQ3 2021Sep 30, 2021$2.70M–
Q4 FY2021CQ2 2021Jun 30, 2021$725.00K-72.6%
Q3 FY2021CQ1 2021Mar 31, 2021-$3.89M–
Q2 FY2021CQ4 2020Dec 31, 2020$1.97M+19.6%
Q1 FY2021CQ3 2020Sep 30, 2020-$888.00K-197.8%
Q4 FY2020CQ2 2020Jun 30, 2020$2.65M+998.3%
Q3 FY2020CQ1 2020Mar 31, 2020-$260.00K-116.5%
Q2 FY2020CQ4 2019Dec 31, 2019$1.65M+89.2%
Q1 FY2020CQ3 2019Sep 30, 2019$908.00K+42.8%
Q4 FY2019CQ2 2019Jun 30, 2019$241.00K-81.6%
Q3 FY2019CQ1 2019Mar 31, 2019$1.58M+224.5%
Q2 FY2019CQ4 2018Dec 31, 2018$872.00K+260.3%
Q1 FY2019CQ3 2018Sep 30, 2018$636.00K-40.1%
Q4 FY2018CQ2 2018Jun 30, 2018$1.31M-0.6%
Q3 FY2018CQ1 2018Mar 31, 2018$486.00K-58.1%
Q2 FY2018CQ4 2017Dec 31, 2017$242.00K-52.1%
Q1 FY2018CQ3 2017Sep 30, 2017$1.06M–
Q4 FY2017CQ2 2017Jun 30, 2017$1.32M–
Q3 FY2017CQ1 2017Mar 31, 2017$1.16M–
Q2 FY2017CQ4 2016Dec 31, 2016$505.00K–

More Pro Dex figures

See a number that looks wrong?